659 related articles for article (PubMed ID: 10178650)
21. The efficacy and safety of pulse vs. continuous therapy for dermatophyte toenail onychomycosis.
Gupta AK; Stec N; Bamimore MA; Foley KA; Shear NH; Piguet V
J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):580-588. PubMed ID: 31746067
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness analysis for onychomycosis therapy in Canada from a government perspective.
Einarson TR; Arikian SR; Shear NH
Br J Dermatol; 1994 Apr; 130 Suppl 43():32-4. PubMed ID: 8186140
[TBL] [Abstract][Full Text] [Related]
23. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
Gupta AK; Gover MD; Lynde CW
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
[TBL] [Abstract][Full Text] [Related]
24. Onychomycosis. New therapies for an old disease.
Gupta AK; Scher RK; De Doncker P; Sauder DN; Shear NH
West J Med; 1996 Dec; 165(6):349-51. PubMed ID: 9000854
[TBL] [Abstract][Full Text] [Related]
25. Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections.
Davis R; Balfour JA
Pharmacoeconomics; 1995 Sep; 8(3):253-69. PubMed ID: 10155621
[TBL] [Abstract][Full Text] [Related]
26. The use of oral antifungal agents to treat onychomycosis.
Gupta AK; Ryder JE
Dermatol Clin; 2003 Jul; 21(3):469-79, vi. PubMed ID: 12956199
[TBL] [Abstract][Full Text] [Related]
27. Oral treatment options for onychomycosis.
Joseph WS
J Am Podiatr Med Assoc; 1997 Nov; 87(11):520-31. PubMed ID: 9397657
[TBL] [Abstract][Full Text] [Related]
28. Oral therapeutic agents in fungal nail disease.
Roberts DT
J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S78-81. PubMed ID: 8077514
[TBL] [Abstract][Full Text] [Related]
29. Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (Diflucan) in the treatment of patients with toenail onychomycosis.
Salo H; Pekurinen M
Pharmacoeconomics; 2002; 20(5):319-24. PubMed ID: 11994041
[TBL] [Abstract][Full Text] [Related]
30. Systemic antifungal therapy for tinea capitis in children.
Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
[TBL] [Abstract][Full Text] [Related]
31. Onychomycosis. Going for cure.
Gupta AK; Shear NH
Can Fam Physician; 1997 Feb; 43():299-305. PubMed ID: 9040916
[TBL] [Abstract][Full Text] [Related]
32. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study.
Sigurgeirsson B; Olafsson JH; Steinsson JB; Paul C; Billstein S; Evans EG
Arch Dermatol; 2002 Mar; 138(3):353-7. PubMed ID: 11902986
[TBL] [Abstract][Full Text] [Related]
33. Onychomycosis: improved cure rates with itraconazole and terbinafine.
Harrell TK; Necomb WW; Replogle WH; King DS; Noble SL
J Am Board Fam Pract; 2000; 13(4):268-73. PubMed ID: 10933291
[TBL] [Abstract][Full Text] [Related]
34. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
Gupta AK; Lynde CW; Konnikov N
J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
[TBL] [Abstract][Full Text] [Related]
35. Oral treatments for toenail onychomycosis: a systematic review.
Crawford F; Young P; Godfrey C; Bell-Syer SE; Hart R; Brunt E; Russell I
Arch Dermatol; 2002 Jun; 138(6):811-6. PubMed ID: 12056964
[TBL] [Abstract][Full Text] [Related]
36. Current trends in onychomycosis therapy: a literature review.
Hecker D
Mt Sinai J Med; 1997 Nov; 64(6):399-405. PubMed ID: 9364835
[TBL] [Abstract][Full Text] [Related]
37. Management of onychomycosis in children.
Gupta AK; De Rosso JQ
Postgrad Med; 1999 Jul; Spec No():31-7. PubMed ID: 10492664
[TBL] [Abstract][Full Text] [Related]
38. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
[TBL] [Abstract][Full Text] [Related]
39. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA
J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
[TBL] [Abstract][Full Text] [Related]
40. [Oral treatment of onychomycosis of the toe nails; comparison of cost effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine].
Neumann HA
Ned Tijdschr Geneeskd; 1995 Jul; 139(26):1350-1. PubMed ID: 7617054
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
